68 Ga RMX VH
Alternative Names: 68Ga-RMX-VH; RMX-VH-GBMLatest Information Update: 28 Apr 2023
At a glance
- Originator RadioMedix; VECT-HORUS
- Class Antineoplastics; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Emission-computed tomography enhancers; Ionising radiation emitters; Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Glioblastoma
- Discontinued Pancreatic cancer
Most Recent Events
- 28 Apr 2023 No recent reports of development identified for research development in Glioblastoma in France (Parenteral)
- 28 Apr 2023 No recent reports of development identified for research development in Glioblastoma(Diagnosis) in France (Parenteral)
- 13 Jul 2021 Discontinued - Preclinical for Pancreatic cancer (Diagnosis) in France (Parenteral), prior to July 2021 (VECT-HORUS pipeline, July 2021)